Research on the Influence of Medical Insurance on Technological Innovation in Medical Industry:Evidence from Serious Illness Insurance in China

Author:

Jiang Ling1

Affiliation:

1. School of Public Administration, Zhongnan University of Economics and Law

Abstract

Abstract Can medical insurance, as an incision, promote technological innovation in the medical industry against the backdrop of China's high-quality development of medical insurance? Using serious illness insurance as an example, this paper employs the multi-period double difference method to assess the impact and mechanism of serious illness insurance on medical device innovation, based on R&D investment data for medical device industry in 29 Chinese provinces from 2007 to 2019. The study found that serious illness insurance considerably increased the development of medical devices. According to a mechanism study, serious illness insurance raises patients' demand for medical care, which increases the number of people who seek treatment, the number of people who stay in hospitals, the number of outpatient visits, and the market for medical devices. According to the adjustment effect, the more beds accessible to regional hospitals and the lower the level of market competition, the more overtly serious illness insurance encourages medical device innovation. This study provides policy insight for supporting high-quality coordinated growth of medical security and pharmaceutical services, as well as a deeper understanding of the logical relationship between medical insurance and technological innovation in the medical industry.

Publisher

Research Square Platform LLC

Reference32 articles.

1. Market size in innovation: theory and evidence from the medical industry;Acemoglu D;Q J Econ,2004

2. Did medicare induce pharmaceutical innovation?;Acemoglu D;Am Econ Rev,2006

3. Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development;Blume-Kohout ME;J Public Econ,2013

4. “ New Agricultural Cooperation": Economic Performance or Health Performance?;Cheng Lingguo Zhang;Eco Res J,2012

5. The determinants of pharmaceutical research and development investments;Civan A;The BE Journal of Economic Analysis & Policy,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3